| Dr Nancy Ann Boelter, MD | |
|
3701 Katz Dr, Marion, IA 52302-3871 | |
| (319) 369-0722 | |
| (319) 362-8574 |
| Full Name | Dr Nancy Ann Boelter |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 3701 Katz Dr, Marion, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629015177 | NPI | - | NPPES |
| 0183731 | Medicaid | IA | |
| 080182348 | Other | IA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 32415 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Care | Cedar rapids, IA | Home health agency |
| Mercy Medical Center - Cedar Rapids | Cedar rapids, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Physician Associates Inc | 1355242496 | 91 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
Genentech, a member of the Roche Group, today announced that Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness
Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.
Researchers at SUNY Downstate Medical Center and Arizona State University have published the first study of levels of parabens - antibacterial substances commonly used as preservatives in cosmetics and other products - in human cord blood samples. The researchers found that a cohort of pregnant women in Brooklyn predominantly of Caribbean- and African-American descent had the highest level worldwide of methyl paraben and propyl paraben.
› Verified 8 days ago
| Entity Name | Mercy Physician Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427254952 PECOS PAC ID: 1355242496 Enrollment ID: O20040120000805 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
Genentech, a member of the Roche Group, today announced that Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness
Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.
Researchers at SUNY Downstate Medical Center and Arizona State University have published the first study of levels of parabens - antibacterial substances commonly used as preservatives in cosmetics and other products - in human cord blood samples. The researchers found that a cohort of pregnant women in Brooklyn predominantly of Caribbean- and African-American descent had the highest level worldwide of methyl paraben and propyl paraben.
› Verified 8 days ago
| Entity Name | Mercycare Management, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467659268 PECOS PAC ID: 2466343363 Enrollment ID: O20040322000692 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
Genentech, a member of the Roche Group, today announced that Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness
Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.
Researchers at SUNY Downstate Medical Center and Arizona State University have published the first study of levels of parabens - antibacterial substances commonly used as preservatives in cosmetics and other products - in human cord blood samples. The researchers found that a cohort of pregnant women in Brooklyn predominantly of Caribbean- and African-American descent had the highest level worldwide of methyl paraben and propyl paraben.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Ann Boelter, MD 3701 Katz Dr, P O Box 260, Marion, IA 52302-3871 Ph: (319) 369-0722 | Dr Nancy Ann Boelter, MD 3701 Katz Dr, Marion, IA 52302-3871 Ph: (319) 369-0722 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
Genentech, a member of the Roche Group, today announced that Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness
Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.
Researchers at SUNY Downstate Medical Center and Arizona State University have published the first study of levels of parabens - antibacterial substances commonly used as preservatives in cosmetics and other products - in human cord blood samples. The researchers found that a cohort of pregnant women in Brooklyn predominantly of Caribbean- and African-American descent had the highest level worldwide of methyl paraben and propyl paraben.
› Verified 8 days ago
James E Mccabe, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2996 7th Ave, Ste B, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Thomas J Richmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 35th St, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Julie Hoffmann, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-373-3022 Fax: 319-373-0208 | |
Deepti Smitha Kurra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2996 7th Ave Ste B, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Arleen Zahn-houser, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-373-8708 Fax: 319-373-8774 | |
Dr. Jaclyn M Price, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-377-3174 Fax: 319-377-9368 | |
Ms. Larae Gail Stemmerman, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 905 29th Ave Ste 120, Marion, IA 52302 Phone: 319-826-6374 Fax: 319-826-6377 |